PHARMACOLOGY 2: • is a new oral direct thrombin inhibitor and the
prodrug of dabigatran

• is a small molecule that reversibly
inhibits both free and clot-bound thrombin by
binding to exosite 1 and/or the active site of
thrombin

Question

• is a new oral direct thrombin inhibitor and the 
prodrug of dabigatran

• is a small molecule that reversibly 
inhibits both free and clot-bound thrombin by 
binding to exosite 1 and/or the active site of 
thrombin

LEIGHTON DWIGHT OBILLOS · Accepted Answer

Dabigatran etexilate

• is a new oral direct thrombin inhibitor and the prodrug of dabigatran • is a small molecule that reversibly inhibits both free and clot-bound thrombin by binding to exosite 1 and/or the active site of thrombin